The role, if any, that mitochondrial (mt) DNA alterations play in the carcinogenic process remains unclear. To determine whether mtDNA instability occurs in cancers, nine microsatellite sequences in the mtDNA were examined in 45 sporadic colorectal carcinomas. Alteration in a polycytidine (C)n tract within a noncoding displacement-loop (D-loop) region was detected in 20 carcinomas (44%), three of which also exhibited frameshift mutations in a polyadenosine (A)8 or polycytidine (C)6 tract within NADH dehydrogenase (ND) genes. Interestingly, all three mutant genes were predicted to encode truncated ND proteins, which lacked a large portion of the C-terminus. These results suggested that certain repair systems, like the mismatch repair systems in the nuclear genome, are required for mtDNA maintenance and that defects in these systems can lead to target mitochondrial gene mutations in colorectal carcinomas.
Introduction
Carcinogenesis is a multistep process involving the accumulation of genetic changes (Bishop, 1993) . Much attention has been directed to genetic events, such as activation of oncogenes, inactivation of tumor suppressor genes and defects of mismatch repair genes (Karp and Broder, 1995) . However, there are still many aspects that cannot be explained by these genetic changes. Somatic cell hybrid studies have demonstrated that tumor-suppressive activity can be involved in the extra-chromosomal fractions (Jonasson and Harris, 1977; Sager, 1985) . This implies that both nuclear and cytoplasmic elements are responsible for the steps of carcinogenesis. Indeed, mitochondrial abnormalities have been observed in many human cancers, including changes in structure, number, respiratory enzyme components and transport systems (Pedersen, 1978; Wilkie et al., 1983) . However, the vast majority of proteins in mitochondria are encoded by the nuclear genome. Therefore, it is not clear whether these mitochondrial abnormalities result from defects in the mitochondrial genome.
Mitochondria contain their own genetic systems for replication, transcription and translation (Wallace, 1992a) . Mitochondrial DNA (mtDNA) is a 16 569-base pair (bp) double-stranded, closed circular molecule, which codes for both a small (12S) and a large (16S) ribosomal RNA gene, 22 transfer RNAs and 13 protein-coding genes. All of the mitochondrial genes encode subunits of the oxidative phosphorylation (OXPHOS) enzymes that are responsible for the energy-generating pathway. MtDNA is thought to be more susceptible to damage by mutagens than nuclear DNA for the following reasons: (a) mtDNA polymerase g replicates the DNA with poor ®delity (Kunkel and Loeb, 1981) , (b) mtDNA is a naked molecule to which chemical carcinogens can easily bind, while nuclear DNA is protected by histones (Backer and Weinstein, 1980; Allen and Coombs, 1980) and (c) a high concentration of reactive oxygen species in mitochondria can induce DNA damage (Oberley and Buettner, 1979) . Indeed, structural changes in mtDNA are common events in various degenerative mitochondrial diseases (Wallace, 1992a,b) . However, only a few studies have demonstrated structural changes in mtDNA in human cancers, including large-scale deletions (450 bp) in gastric (Burgart et al., 1995) and renal cell (Horton et al., 1996) carcinomas. Almost all other studies of cancer have described changes in mitochondrial gene expression (Heerdt et al., 1990; Sharp et al., 1992) . This observation prompted us to speculate that some DNA repair mechanisms are potentially involved in maintenance of the normal mitochondrial genome.
Hypermutable status (instability) in the nuclear genome has been observed in certain types of cancers, in which microsatellite sequences are preferentially aected due to slippage during the replication process (Ionov et al., 1993; Aaltonen et al., 1993; Thibodeau et al., 1993) . These replication error phenotypes are related to functional loss of mismatch repair (MMR) genes, including the hMSH2, hMLH1, hPMS1 and hPMS2 genes (Parsons et al., 1993; Boyer et al., 1995) . On the other hand, in the mitochondrial genome, the MMR system has been found only in yeast strains, in which MSH1 and MSH2 are separately involved in mitochondrial and nuclear DNA repair systems, respectively (Reenan and Kolodner, 1992) . No MSH1 homologue has been found in mammalian cells and therefore, it remains uncertain whether an MMR system plays a role in the maintenance of mammalian mitochondrial genome.
The aim of the present study was to determine whether certain MMR systems play a role in mtDNA maintenance and whether impairment of this system can lead to a hypermutable status of mtDNA in cancer cells. Thus, we evaluated mitochondrial microsatellite instability (MSI) in the non-coding D-loop region because any alterations in the coding region can aect mitochondrial function and as a result lead to exclusion by negative selection after mitochondrial segregation. Two simple repeat sequences in the Dloop region were then examined in 45 colorectal carcinomas. We also examined mutations in seven independent repeat sequences in the mitochondrial coding region to determine whether mitochondrial MSI can be associated with speci®c mitochondrial gene mutations. Because the mitochondrial genome is highly heterogeneous (heteroplasmy), analysis needs to be performed using pure normal or carcinoma cells for accurate estimation. Therefore, in the present study, we applied a crypt isolation technique (Habano et al., in press; Habano et al., 1996; Nakamura et al., 1993 Nakamura et al., , 1994 Yoshida et al., 1996) that allows the complete separation of non-neoplastic and neoplastic crypts from stromal cells.
Results

Alterations in mtDNA in the D-loop region
Two distinct microsatellite sequences within the mitochondrial D-loop region were examined for mutations in 45 sporadic colorectal carcinomas. A 157-bp portion including a polycytidine (C)n tract (Burgart et al., 1995) was examined using the polymerase chain reaction-single strand conformation polymorphism (PCR ± SSCP) method. Twenty carcinomas (44%) exhibited abnormal bands with dierent mobilities (Figure 1 ). Direct DNA sequencing revealed that most alterations consisted of deletion or insertion of cytidine residues in the (C)n tract ( Figure 2 , case 59 and 57). Two cases revealed more obvious changes in this region (Figure 2 , case 501). None of the individuals examined had the same repeat number in germline status (normal mucosa) (7 4n 49), suggesting that this variation re¯ected a neutral polymorphism with respect to mitochondrial function. Some normal and carcinoma tissue contained two distinct mtDNA subpopulations with respect to (C)n status (heteroplasmy). In some cases, a mtDNA subpopulation that appeared to be speci®c to carcinoma tissue in the SSCP analysis was also detectable in the normal counterpart using direct sequencing ( Figure 2 , case 59). Such cases revealed a dierent proportion of mtDNA subpopulations between normal and carcinoma tissue. Whether Figure 1 PCR ± SSCP analysis in the mitochondrial D-loop region. Cases 57 and 59 exhibited dierent mobilities in carcinoma tissue (C), compared to each normal counterpart (N), while cases 84 and 506 exhibited no mobility shift. Case 501 showed more obvious changes in this region. All alterations were detectable in both single-strand (ss) and double-strand (ds) DNA patterns Figure 2 Direct sequencing of the mitochondrial D-loop region. In case 59C, the (C)n status of the major population changed from (C)8 to (C)7, but normal tissue (59N) contained a minor (C)7 subpopulation. Arrowheads`T (thymidine)' and`C (cytidine)' indicate (C)7 and (C)8 subpopulations, respectively. In case 57, the (C)8 population was completely exchanged to (C)9. Case 501 showed more extensive change, but the altered sequence could not be determined mtDNA instability in colorectal carcinoma W Habano et al the alterations resulted from sequence changes (genuine mutations) or simply re¯ected changes in the proportion of mtDNA subpopulations during mitochondrial segregation could not be determined. Therefore, these alterations were comprehensively characterized as changes in mitochondrial heteroplasmy (CMH) and distinguished from genuine mutations that were never detected in normal counterparts (Figure 3) . If the cases with CMH were excluded from the positive group with mitochondrial instability, mtDNA alterations in this region were found in nine cases (20%). The other D-loop portion including a dinucleotide (CA)n repeat sequence was examined by electrophoresis under denaturing conditions using an automated DNA sequencer. A polymorphism with respect to the repeat number was observed among normal tissues (4 4n 47). However, none of the carcinomas exhibited alterations in this (CA)n tract in comparison with each normal counterpart. Thus, microsatellite alteration in the mitochondrial D-loop region (MSI) occurred commonly in the (C)n tract, but not in the (CA)n tract, in colorectal carcinomas.
Mutations in the coding region of mtDNA
In order to determine whether microsatellite alteration occurred in the mitochondrial coding regions, seven independent repeat sequences (Table 1) were examined using an automated DNA sequencer. As shown in Table 2 , three cases (7%) revealed mutations in one of these sequences. Case 505C exhibited a cytidine deletion in the (C)6 tract within the NADH dehydrogenase 5 (ND5) gene (Figure 4 ). This frameshift mutation created a stop codon (TAA) down- Figure 3 Patterns of mtDNA alteration. For the purpose of simpli®cation, distribution of mtDNA in normal or carcinoma tissue is schematically displayed in a single cell. MtDNA population is homoplasmic (a) or heteroplasmic (b),(c) with respect to (C)n status in normal cells. If a certain population with dierent (C)n status (open-triangle) is detected in carcinoma cells, the alteration is de®ned as a genuine mutation that indicates sequence change in this (C)n tract ((a) and (b)). If only a proportion of distinct mtDNA subpopulations is changed in carcinoma cells without any dierent subpopulations (c), this alteration is de®ned as a change in mitochondrial heteroplasmy (CMH) and is distinguished from a genuine mutation mtDNA instability in colorectal carcinoma W Habano et al stream and was predicted to encode a truncated ND5 protein (a change from 603 to 35 amino acids). The mutant mtDNA was homoplasmic throughout carcinoma tissue. Case 124 and 20 (Figure 4 ) also exhibited frameshift mutations in the (A)8 and (C)6 tracts and created mitochondria-speci®c stop codons AGA and AGG, respectively. The three carcinomas also showed alterations in the (C)n sequences within the D-loop region. None except the above three cases exhibited alterations in the coding repeat sequences examined. Thus, microsatellite alteration in the mitochondrial coding region was observed in some colorectal carcinomas, and appears to be associated with alteration in the D-loop region.
Discussion
We assessed mtDNA instability in the non-coding Dloop region in 45 colorectal carcinomas. Burgart et al. (1995) demonstrated that mtDNA alterations in the Dloop region are found in gastric cancers (12.5%); all of their series had deletions in the 50 bp portion including the (C)n tract. Heerdt et al. (1994) examined colorectal carcinomas in the promoter region adjacent to the (C)n tract and found neither mutation nor instability. In the present study, mtDNA alterations within the D-loop region were frequently detected in colorectal carcinomas (44%), most of which involved insertion or deletion of a cytidine in the (C)n sequence. None of the cases revealed such large-scale deletions as Burgart et al. demonstrated in gastric carcinomas. Some positive cases exhibited genuine mutations, but the other positive cases exhibited changes in mitochondrial heteroplasmy (CMH) with respect to (C)n status ( Figure 3) . We assume that the CMH in the mitochondrial genome plays a role in colorectal carcinogenesis, because many carcinomas that showed heteroplasmy in the normal counterparts retained exactly the same proportion of mtDNA subpopulations. We believe that the real status of mitochondrial heteroplasmy was able to be estimated in this study, because mtDNA was obtained from pure normal or neoplastic cells using the crypt isolation technique.
The (C)n tract is located in a conserved sequence block 2 (CSB2) that is an essential element for mtDNA replication (Chang et al., 1985) . We have not found any evidence for a change in replication or transcrip- Figure 4 Direct sequencing of the mitochondrial ND5 and ND1 genes. In case 505, a cytidine deletion in the (C)6 tract in the ND5 gene resulted in the (C)5 in carcinomas, with the status of homoplasmy. In case 20, a cytidine insertion in the (C)6 tract in the ND1 gene resulted in the (C)7 in carcinomas, with the status of heteroplasmy. Arrowheads`T (thymidine)' and`C (cytidine)' indicate (C)6 and (C)7 subpopulations, respectively Parsons et al. (1997) which proves a high substitution rate in this sequence. Because of aspects similar to nuclear genomic instability characterized as (CA)n alteration (Aaltonen et al., 1993; Thibodeau et al., 1993) , the (C)n alterations probably re¯ect microsatellite instability (MSI) in the mitochondrial genome. On the other hand, because we used total cellular DNA including both mitochondrial and nuclear genome in the present study, the possibility that we examined mtDNA-like sequences in the nuclear genome cannot be excluded (Fukuda et al., 1985) . However, the ampli®ed sequence around the (C)n tract was completely consistent with the mtDNA sequence previously reported (Anderson et al., 1981) . In addition, there is no evidence that mtDNA sequences are stably integrated into the nuclear genome in human cells. Therefore, we believe that genetic instability detected in the present study occurred in the mitochondrial genome, but not in the nuclear genome. The results also indicate that certain repair systems, like mismatch repair (MMR) systems in the nuclear genome, play a role in the maintenance of the mitochondrial genome in human cells. Consequently, repair de®ciencies may lead to mtDNA instability in some colorectal carcinomas. In contrast, none of the cases exhibited instability in the (CA)n tract, although the alteration in this tract is also thought to be neutral with respect to mitochondrial function. Heerdt et al. (1994) also found no alteration in the same (CA)n tract in colorectal carcinomas. We believe that relatively small repeat numbers (4 4n 47) in the normal status prevent the creation of slippage mutations in this tract. also showed that the probability of maintaining a nuclear microsatellite sequence in MMR-de®cient cells is inversely proportional to the length of the microsatellite tract. The similarity in the target speci®city suggests that both mitochondrial and nuclear MSI may result from the same mechanism, by which MMR de®ciencies lead to slippage mutation during the replication process. On the other hand, mtDNA mutations in the coding region were detected in three cases (505, 124 and 20) . Because each mutant mtDNA was not detected in the normal counterpart (Figure 4) , these mutations re¯ected the generation of new mutant mtDNA during cancer development. The cases 505 and 124 showed frameshift mutations in the ND5 gene and predictably led to truncated proteins that lacked a large portion of the C-terminus. Interestingly, these mtDNA mutations were homoplasmic throughout the carcinoma tissue. It seems unlikely that only a minor component of mutant mtDNA has accumulated in each carcinoma tissue without any selection because the number of mitochondrial genomes per cell is quite large (Shay and Werbin, 1987) . In a yeast model (Bernardi, 1979) , a truncated mitochondrial genome can gain a selective advantage over normal mitochondrial genomes due to faster replication. However, an insertion or deletion of only one nucleotide in the ND5 sequence most likely did not result in a replicative advantage over normal mitochondrial genomes. Therefore, the truncated ND5 proteins probably conferred some speci®c cell growth advantage. This also indicates that the ND5 mutations did not result from non-random targeting of mitochondrial MSI. The other case 20 was a frameshift mutation in a polycytidine tract (C)6 in the ND1 gene and predictably led to a truncated protein. This ND1 mutation may also be important in colorectal carcinogenesis because a large amount of the mutant (C)7 population had accumulated in the carcinoma tissue.
Interestingly, the three cases also exhibited alterations in the (C)n tract in the D-loop region. Therefore, the ND1 or ND5 gene may be one of the target genes for mitochondrial MSI in colorectal carcinomas. The situation is similar to that in the nuclear genome, in which mutations in the mononucleotide repeat sequence in the transforming growth factor btype II receptor , insulin-like growth factor II receptor (Souza et al., 1996) and BAX (Rampino et al., 1997) genes are preferentially observed in colorectal carcinomas with MSI. We found that the mitochondrial genome has no repeat sequence that consists of more than eight mononucleotides. Therefore, mtDNA instability in the coding region may not be frequently detected in colorectal carcinomas. However, other mitochondrial repeat sequences that we had not examined in this study may have been aected in these carcinomas.
Both ND5 and ND1 gene products are subunits of the NADH dehydrogenase complex. Horton et al., (1996) detected mtDNA deletions in the ND1 region in renal cell carcinomas, suggesting that functional changes in a NADH dehydrogenase component may signi®cantly in¯uence carcinogenesis, although these alterations most likely do not accelerate tumor cell growth directly. One attractive hypothesis (Bandy and Davison, 1990) is that damage to the mitochondrial gene may result in impaired function of normal respiration and release abnormally high levels of reactive oxygen species, which amplify damage to the nuclear genome (such as oncogenes and suppressor genes). Ozawa (1995) also suggested that production of reactive oxygen species can be synergistically enhanced by the malignant cycle and results in mtDNA mutations and deletions. These hypotheses provide a possible mechanism by which speci®c mitochondrial mutations promote carcinogenesis. In contrast, abnormal mitochondrial gene products may also lead to lethal changes in mitochondrial respiratory functions. However, structural and functional changes in mitochondria are found in various human cancer cells (Wilkie et al., 1983) and some of these cancers reveal remarkable defects in respiratory metabolism. Therefore, certain cancer cells, even if they are rapidly growing, appear to adapt to life under anaerobic conditions. Also interesting is that, in the present study mtDNA instability in the D-loop region correlated with nuclear genomic instability (data not shown). The results suggest that nuclear and mitochondrial genomes partly share the same DNA repair system. In our previous study (Habano et al., 1998) , loss of the hMSH2 and hMLH1 genes was observed in 21% and 20% of the same series of colorectal carcinomas, respectively. However, mtDNA instability was not mtDNA instability in colorectal carcinoma W Habano et al associated with these gene defects, suggesting that a certain MMR enzyme other than hMSH2 or hMLH1 may be responsible for maintenance in both nuclear and mitochondrial genomes. In contrast, some carcinomas with mtDNA instability, including cases 505, 124 and 20 in the present study that showed ND gene mutations, do not exhibit any nuclear MSI. Therefore, it is more likely that there is another MMR system speci®c to mitochondrial genome maintenance. The situation is similar to MMR systems in yeast strains, in which maintenance of the mitochondrial and nuclear genomes is separately regulated by MSH1 and MSH2, respectively. We suggest that an MSH1-like enzyme plays a role in mtDNA maintenance in mammalian cells.
To our knowledge, this is the ®rst study to identify microsatellite instability in the mitochondrial genome of carcinomas. Certain mitochondrial gene mutations (ND1 and ND5) were associated with the mtDNA instability, suggesting that unknown mismatch repair systems play a role in mtDNA maintenance and that repair defects lead to speci®c mitochondrial gene mutations in carcinomas. Therefore, alterations in the mitochondrial genome, in combination with alterations in nuclear oncogenes and tumor suppressor genes, may be important in the process of a certain type of colorectal carcinoma. Hence, more attention must be focused on the role of the mitochondrial genome in carcinogenesis.
Materials and methods
Crypt isolation and DNA extraction
Forty-®ve tissue specimens were obtained from 44 patients (31 male and 14 female) with primary colorectal carcinomas. Corresponding tissue specimens were obtained from normal mucosa located distal to the tumor. All specimens were surgically resected at Iwate Medical University Hospital, Morioka, Japan, between 1993 and 1995, as described previously (Habano et al., 1998) . Crypt isolation and total cellular DNA extraction were performed as previously described (Habano et al., 1996) .
PCR ± SSCP analysis
To screen for mutations in a 157-bp portion (Burgart et al., 1995) of the mitochondrial D-loop region, nonRI PCR ± SSCP analysis was performed as described previously (Habano et al., 1996) . PCR products were electrophoresed at 300 V at 238C for 2 h through a 7.5% polyacrylamide gel (138613061 mm) containing 50 mM Tris-base, 50 mM boric acid and 1 mM EDTA. After silver staining, DNA fragments that reproducibly showed mobility shifts according to independent two-repeated SSCP analyses were subjected to direct sequencing using dye-labeled dideoxynucleoside triphosphates as terminators and analysed using an automated DNA sequencer (Smith et al., 1986) .
Microsatellite analysis
Mutations in eight independent microsatellite sequences were examined using a model 373A automated¯uorescent DNA sequencer and GENESCAN TM 672 (Version 1.2.2-1, Perkin-Elmer Cetus, Norwalk, Connecticut). The primers for ampli®cation of each microsatellite sequence are listed in Table 1 . Each antisense primer was labeled with 6-FAM, TET or HEX¯uorescent dye. PCR was performed as previously described (Habano et al., 1996) , although the annealing temperature was 578C for all reactions. Carcinoma samples reproducibly showing extra DNA signals according to two-repeated GENESCAN analyses were subjected to direct sequencing.
